[go: up one dir, main page]

DK1787126T3 - Fremgangsmåde til karakterisering af en polyklonal cellelinie - Google Patents

Fremgangsmåde til karakterisering af en polyklonal cellelinie

Info

Publication number
DK1787126T3
DK1787126T3 DK05760790T DK05760790T DK1787126T3 DK 1787126 T3 DK1787126 T3 DK 1787126T3 DK 05760790 T DK05760790 T DK 05760790T DK 05760790 T DK05760790 T DK 05760790T DK 1787126 T3 DK1787126 T3 DK 1787126T3
Authority
DK
Denmark
Prior art keywords
cell line
polyclonal
platform
polyclonal cell
characterizing
Prior art date
Application number
DK05760790T
Other languages
Danish (da)
English (en)
Inventor
Torben Frandsen
Lone Kjaer Rasmussen
Soeren Kofoed Rasmussen
Peter Sejer Andersen
Original Assignee
Symphogen As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symphogen As filed Critical Symphogen As
Application granted granted Critical
Publication of DK1787126T3 publication Critical patent/DK1787126T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/96Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation using ion-exchange
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Document Processing Apparatus (AREA)
DK05760790T 2004-07-20 2005-07-20 Fremgangsmåde til karakterisering af en polyklonal cellelinie DK1787126T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200401133 2004-07-20
DKPA200401991 2004-12-22
PCT/DK2005/000504 WO2006007853A2 (fr) 2004-07-20 2005-07-20 Procedure de caracterisation structurelle d'une proteine polyclonale recombinee ou d'une lignee de cellules polyclonales

Publications (1)

Publication Number Publication Date
DK1787126T3 true DK1787126T3 (da) 2009-12-21

Family

ID=35427551

Family Applications (2)

Application Number Title Priority Date Filing Date
DK05760790T DK1787126T3 (da) 2004-07-20 2005-07-20 Fremgangsmåde til karakterisering af en polyklonal cellelinie
DK09151073.5T DK2053408T3 (da) 2004-07-20 2005-07-20 Fremgangsmåde til strukturel karakterisering af et rekombinant polyklonalt protein eller en polyklonal cellelinje

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK09151073.5T DK2053408T3 (da) 2004-07-20 2005-07-20 Fremgangsmåde til strukturel karakterisering af et rekombinant polyklonalt protein eller en polyklonal cellelinje

Country Status (18)

Country Link
US (2) US8288109B2 (fr)
EP (2) EP1787126B1 (fr)
JP (1) JP4870667B2 (fr)
KR (1) KR101319848B1 (fr)
AT (2) ATE443870T1 (fr)
AU (1) AU2005263334C1 (fr)
BR (1) BRPI0513714A (fr)
CA (1) CA2574146C (fr)
DE (1) DE602005016818D1 (fr)
DK (2) DK1787126T3 (fr)
ES (2) ES2332524T3 (fr)
IL (2) IL180169A (fr)
MX (1) MX2007000551A (fr)
NO (1) NO20070931L (fr)
NZ (1) NZ552264A (fr)
PL (2) PL2053408T3 (fr)
RU (1) RU2426795C2 (fr)
WO (1) WO2006007853A2 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2512647C (fr) * 2003-01-07 2013-10-08 Symphogen A/S Methode de production de proteines polyclonales de recombinaison
TWI333977B (en) 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
BRPI0513706A (pt) 2004-07-20 2008-05-13 Symphogen As anticorpo policlonal recombinante anti-rhesus d e métodos de produção
RU2426795C2 (ru) 2004-07-20 2011-08-20 Симфоген А/С Способ структурной характеристики рекомбинантного поликлонального белка или поликлональной клеточной линии
JP2009518320A (ja) * 2005-12-05 2009-05-07 シュムフォウエン アクティーゼルスカブ 抗オルトポックスウイルス組換えポリクローナル抗体
US8338376B2 (en) 2006-10-20 2012-12-25 Biogen Idec Ma Inc. Compositions comprising variant LT-B-R-IG fusion proteins
MX2009008908A (es) * 2007-03-01 2009-08-28 Symphogen As Metodo para clonacion de anticuerpos analogos.
PL2132229T3 (pl) * 2007-03-01 2016-12-30 Kompozycje rekombinowanych przeciwciał anty-receptor czynnika wzrostu naskórka
CN101679513A (zh) * 2007-03-06 2010-03-24 西福根有限公司 用于治疗呼吸道合胞病毒感染的重组抗体
EP2139509A2 (fr) * 2007-03-15 2010-01-06 Biogen Idec MA, Inc. Traitement de troubles auto-immuns
JP2008289483A (ja) * 2007-05-25 2008-12-04 Symphogen As 真核生物系において発現可能な形質転換体のスクリーニング
NZ581316A (en) * 2007-05-25 2012-02-24 Symphogen As Method for manufacturing a recombinant polyclonal protein
CN101821289A (zh) * 2007-09-07 2010-09-01 西福根有限公司 重组制造抗rsv抗体的方法
CA2702322A1 (fr) 2007-11-22 2009-05-28 Symphogen A/S Procede de caracterisation d'une proteine polyclonale recombinante
BRPI0910454A2 (pt) * 2008-04-23 2018-03-27 Symphogen As processo para produção de uma proteína policlonal
EP2331577B1 (fr) 2008-08-29 2017-06-07 Symphogen A/S Compositions de l'anticorps de recombinaison anti-récepteur du facteur de croissance anti-épidermique egfr
MX2011001930A (es) * 2008-08-29 2011-04-21 Symphogen As Metodo para clonar anticuerpos derivados de aves.
US8821879B2 (en) 2009-09-04 2014-09-02 Xoma Technology Ltd. Anti-botulism antibody coformulations
JP2013507603A (ja) * 2009-10-09 2013-03-04 シムフォゲン・アクティーゼルスカブ 署名ペプチドおよび質量分析による混合物中の個々の組換えタンパク質の多重定量化
EP2558494B1 (fr) * 2010-04-15 2018-05-23 AbbVie Inc. Protéines de liaison à la bêta amyloïde
ES2692379T3 (es) 2010-11-01 2018-12-03 Symphogen A/S Anticuerpos anti-HER3 y composiciones
JP2016514091A (ja) 2013-02-08 2016-05-19 ミスフォールディング ダイアグノスティクス, インコーポレイテッド トランスサイレチン抗体およびその使用
EP3729958B1 (fr) * 2013-03-15 2023-05-03 Mayo Foundation for Medical Education and Research Identification et surveillance d'immunoglobulines monoclonales par la masse moléculaire
UY35517A (es) 2013-04-04 2014-10-31 Mabxience S A Un procedimiento para aumentar la formación de ácido piroglutamico de una proteína
WO2015093925A1 (fr) * 2013-12-19 2015-06-25 CASTRO ALDRETE, Jorge Isaac Méthode de production d'anticorps spécifiques
TW201623331A (zh) * 2014-03-12 2016-07-01 普羅帝納生物科學公司 抗黑色素瘤細胞黏著分子(mcam)抗體類及使用彼等之相關方法
US11680948B2 (en) 2016-08-12 2023-06-20 Abreos Biosciences, Inc. Detection and quantification of natalizumab
GB201710691D0 (en) * 2017-07-04 2017-08-16 Ge Healthcare Bio Sciences Ab Method in bioprocess purification system
MA52945A (fr) * 2018-06-22 2021-04-28 Genmab As Procédé de production d'un mélange contrôlé d'au moins deux anticorps différents
CN112816595A (zh) * 2021-01-06 2021-05-18 海默斯(重庆)医学生物技术有限公司 一种重组角蛋白液体制剂及其纯度检测方法
WO2025038736A1 (fr) * 2023-08-15 2025-02-20 Gigagen, Inc. Procédés d'analyse de protéines polyclonales recombinantes

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0162918A1 (fr) 1983-11-28 1985-12-04 The Board Of Trustees Of The Leland Stanford Junior University ANTICORPS MONOCLONAL HUMAIN CONTRE L'ANTIGENE Rh(D) ET SES UTILISATIONS
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines
CA1293460C (fr) 1985-10-07 1991-12-24 Brian Lee Sauer Recombinaison a des sites specifiques de l'adn dans les levures
US5126130A (en) 1986-11-24 1992-06-30 The Childrens Hospital Incorporated Monoclonal antibodies reactive with specific antigenic sites on human cytomegalovirus glycoprotein a
GB8722019D0 (en) 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8722018D0 (en) 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8722020D0 (en) 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
WO1990005144A1 (fr) 1988-11-11 1990-05-17 Medical Research Council Ligands a domaine unique, recepteurs comprenant lesdits ligands, procedes pour leur production, et emploi desdits ligands et recepteurs
GB8906129D0 (en) 1989-03-17 1989-05-04 Central Blood Lab Authority Pharmaceutical preparations
GB8919761D0 (en) 1989-09-01 1989-10-18 Central Blood Lab Authority Chemical compounds
WO1992015694A1 (fr) 1991-03-08 1992-09-17 The Salk Institute For Biological Studies Modification de genes induite par recombinase dans des cellules de mammifere, compositions et cellules utiles a cet effet
US5837268A (en) * 1991-10-16 1998-11-17 University Of Saskatchewan GnRH-leukotoxin chimeras
US5252216A (en) * 1992-03-24 1993-10-12 Smithkline Beecham Corporation Protein purification
PL302438A1 (en) 1992-06-26 1994-07-25 Aetsrn Human anti-rh(d) monoclonal antibodies and cellular lines producing them
US5538848A (en) 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
DK1231268T3 (da) 1994-01-31 2005-11-21 Univ Boston Polyklonale antistofbiblioteker
FR2724182B1 (fr) 1994-09-02 1996-12-13 Pasteur Institut Obtention d'un anticorps monoclonal recombinant a partir d'un anticorps monoclonal humain anti-rhesus d, sa production en cellules d'insecte, et ses utilisations
US6111166A (en) 1994-09-19 2000-08-29 Medarex, Incorporated Transgenic mice expressing human Fcα and β receptors
EP0920509B1 (fr) 1996-06-24 2004-07-28 ZLB Bioplasma AG Polypeptides capables de former des structures de liaison a l'ant igene avec une specificite pour les antigenes de rhesus d, adn les codant et procede pour leur preparation et leur utilisation
US6255455B1 (en) 1996-10-11 2001-07-03 The Trustees Of The University Of Pennsylvania Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof
US5876925A (en) 1996-10-11 1999-03-02 The Trustees Of The University Of Pennsylvania Magnetically activated cell sorting for production of proteins
CA2283740C (fr) 1997-03-14 2006-06-27 Idec Pharmaceuticals Corporation Procede pour integrer des genes a des sites specifiques dans des cellules de mammifere par recombinaison homologue et vecteurs utilises pour la mise en oeuvre de ce procede
JPH11174038A (ja) * 1997-12-10 1999-07-02 Tosoh Corp 蛋白質の分離精製法
US6632672B2 (en) 1998-08-19 2003-10-14 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for genomic modification
US20020155114A1 (en) 1998-08-31 2002-10-24 James D. Marks Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
WO2001006233A1 (fr) * 1999-07-16 2001-01-25 Human Genome Sciences, Inc. Surveillance en temps reel et in situ et supervision, en reaction a une spectroscopie aux infrarouges, d'un processus de biofabrication
DK1234022T3 (da) 1999-07-23 2010-07-19 Univ California DNA-rekombination i eukaryote celler med bakteriofag PHIC31-rekombinationssystemet
EP1106625A1 (fr) 1999-11-17 2001-06-13 ZLB Bioplasma AG Séquences péptidiques spécifiques pour rhesus D
EP1358202A2 (fr) 2000-02-08 2003-11-05 The Regents Of The University Of Michigan Separation et affichage de proteines
JP2003534533A (ja) 2000-02-08 2003-11-18 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン タンパク質のディファレンシャルディスプレイのマッピング
AU2001234893A1 (en) 2000-02-08 2001-08-20 The Regents Of The University Of Michigan Protein mapping
EP1283720B1 (fr) 2000-05-26 2007-04-18 Symphogen A/S Anticorps polyclonaux recombines ou purifies, destines au traitement des allergies
US6610472B1 (en) 2000-10-31 2003-08-26 Genetastix Corporation Assembly and screening of highly complex and fully human antibody repertoire in yeast
EP1337631A2 (fr) * 2000-11-28 2003-08-27 Applied Molecular Evolution, Inc. Bibliotheques d'expression eucaryotes et methodes d'utilisation eukaryotic expression libraries and methods of use
DE60142650D1 (de) 2000-12-26 2010-09-02 Inst Systems Biology Seattle Schnelle und quantitative Proteomanalyse und entsprechende Verfahren
US7541003B2 (en) * 2001-07-17 2009-06-02 Bio-Rad Laboratories, Inc. Latex based adsorbent chip
ATE327512T1 (de) * 2001-12-08 2006-06-15 Micromass Ltd Massenspektrometrie-verfahren
AU2003237282A1 (en) 2002-05-31 2003-12-19 The Regents Of The University Of Michigan Automated protein analysis system comprising capillary electrophoresis-tandem mass spectrometry
SI1523496T1 (sl) * 2002-07-18 2011-11-30 Merus B V Rekombinantno proizvajanje zmesi protiteles
JP2004101477A (ja) * 2002-09-12 2004-04-02 Yoshio Yamauchi 2次元高速液体クロマトグラフ装置及びそれを用いた蛋白質分析装置
WO2004035169A2 (fr) 2002-10-15 2004-04-29 The Regents Of The University Of Michigan Systeme de separation multidimensionelle des proteines
US20060275766A1 (en) * 2003-01-07 2006-12-07 Haurum John S Method for manufacturing recombinant polyclonal proteins
CA2512647C (fr) * 2003-01-07 2013-10-08 Symphogen A/S Methode de production de proteines polyclonales de recombinaison
TWI333977B (en) 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
BRPI0513706A (pt) 2004-07-20 2008-05-13 Symphogen As anticorpo policlonal recombinante anti-rhesus d e métodos de produção
RU2426795C2 (ru) 2004-07-20 2011-08-20 Симфоген А/С Способ структурной характеристики рекомбинантного поликлонального белка или поликлональной клеточной линии
JP2009518320A (ja) 2005-12-05 2009-05-07 シュムフォウエン アクティーゼルスカブ 抗オルトポックスウイルス組換えポリクローナル抗体
KR20080113223A (ko) 2006-03-06 2008-12-29 심포젠 에이/에스 호흡기세포 융합 바이러스 감염 치료용 재조합 폴리클로날 항체
CA2702322A1 (fr) 2007-11-22 2009-05-28 Symphogen A/S Procede de caracterisation d'une proteine polyclonale recombinante

Also Published As

Publication number Publication date
NZ552264A (en) 2010-03-26
EP2053408B1 (fr) 2012-03-07
RU2426795C2 (ru) 2011-08-20
WO2006007853A3 (fr) 2006-05-18
ATE443870T1 (de) 2009-10-15
WO2006007853A2 (fr) 2006-01-26
JP4870667B2 (ja) 2012-02-08
NO20070931L (no) 2007-04-17
BRPI0513714A (pt) 2008-05-13
CA2574146C (fr) 2015-06-30
AU2005263334B2 (en) 2010-08-05
DE602005016818D1 (de) 2009-11-05
EP1787126A2 (fr) 2007-05-23
IL180169A (en) 2011-04-28
IL203017A (en) 2013-08-29
EP2053408A2 (fr) 2009-04-29
KR101319848B1 (ko) 2013-10-18
US8288109B2 (en) 2012-10-16
CA2574146A1 (fr) 2006-01-26
US9029091B2 (en) 2015-05-12
KR20070032078A (ko) 2007-03-20
DK2053408T3 (da) 2012-06-04
EP1787126B1 (fr) 2009-09-23
US20080131882A1 (en) 2008-06-05
JP2008506960A (ja) 2008-03-06
ES2332524T3 (es) 2010-02-08
ATE548657T1 (de) 2012-03-15
IL180169A0 (en) 2007-06-03
HK1133076A1 (en) 2010-03-12
HK1101043A1 (en) 2007-10-05
ES2381531T3 (es) 2012-05-29
RU2007106050A (ru) 2008-08-27
PL2053408T3 (pl) 2012-08-31
AU2005263334C1 (en) 2011-01-20
AU2005263334A1 (en) 2006-01-26
US20130203063A1 (en) 2013-08-08
MX2007000551A (es) 2007-03-30
PL1787126T3 (pl) 2010-03-31
EP2053408A3 (fr) 2009-07-29

Similar Documents

Publication Publication Date Title
DK1787126T3 (da) Fremgangsmåde til karakterisering af en polyklonal cellelinie
MX2010005377A (es) Metodo para caracterizacion de proteina policlonal recombinante.
BRPI0507433C1 (pt) anticorpo monoclonal recombinante ou sua parte de ligação ao antígeno, composição, ácido nucleico isolado, vetor de expressão, e, kit
EA201590631A1 (ru) Антигенсвязывающие белки, способные связывать тимусный стромальный лимфопоэтин
ATE554390T1 (de) Verfahren zur gewinnung von antikörpern
EA200700917A1 (ru) Способ рефолдинга рекомбинантных антител
EA200700751A1 (ru) Способы и композиции для улучшения продуцирования рекомбинантного белка
WO2005066867A3 (fr) Modulateurs de recepteurs
BRPI0820885B8 (pt) "anticorpo ou fraguimento do mesmo, célula de hibridoma, polinucleotídeo, polipeptídeo compreendendoum domínio de cadeia pesada ou leve de anticorpo, método para detecção de gravidez em um animal bovino, kit e método de purificação de um antígeno principal associado à gravidez (pag)".
DK2185937T3 (da) Fremgangsmåde til at bestemme sepsis hos mennesker
WO2009132132A3 (fr) Prédiction du risque d’un individu de développer une polyarthrite rhumatoïde
WO2005019831A3 (fr) Procedes pour la reduction de la complexite d'un echantillon au moyen d'anticorps a des sites antigeniques de petite dimension
DE602005013947D1 (de) Antikörper gegen hundepankreaslipase
WO2005106494A3 (fr) Anticorps monoclonaux, hybridomes, procede ameliore pour la determination de la proteine ptx3 et trousse pour ladite determination
WO2004084841A3 (fr) Nouveaux anticorps d'albumine anti-feline et procedes de detection de maladies renales precoces
DE50212790D1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
WO2006033974A3 (fr) Detection d'agregats de proteines au moyen d'un dosage elisa homologue
ATE423133T1 (de) Verfahren und materialien zur behandlung von entzündungen unter verwendung eines polypeptides das einen eigenen-c5 aminosaüresegment und einen nicht-eigenen aminosaüresegment enthält
DK1539817T3 (da) Immunoassays til specifik bestemmelse af SCCA-isoformer
DE602005022757D1 (de) Verwendung von endosialinbindenden proteinen zum isolieren endosialinpositiver zellen
WO2005058362A3 (fr) Procede d'ouverture de jonctions serrees
Mehand et al. Estimation of analyte concentration by surface plasmon resonance-based biosensing using parameter identification techniques
Anuleejun Production of fusion protein IL-2/FU-MK-1-scFv by Pichia pastoris in fermenter and characterization of partially purified fusion protein
Sutarut Production of monoclonal antibodies specific to vitellogenin and zona radiata proteins in greenback mullet, Liza subviridis
AR127806A1 (es) Anticuerpos b7-h4 y proteínas de fusión de anticuerpo b7-h4 / il-15